Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
AstraZeneca in broad drug deal with Bicycle worth up to $1 billion
AstraZeneca has signed a wide-ranging deal with private biotech firm Bicycle Therapeutics to develop a novel class of small molecule medicines for treating respiratory, cardiovascular and metabolic di...
Johnson & Johnson hit with over $1 billion verdict on hip implants
A federal jury in Dallas on Thursday ordered Johnson & Johnson (JNJ.
UN’s Ban apologizes to people of Haiti, outlines new plan to fight cholera epidemic and help communities
United Nations Secretary-General Ban Ki-moon today apologized to the people of Haiti, expressing deep regret for the loss of life and suffering caused by the country’s cholera epidemic, and outlined...
Takeda to Invest More Than 100 Million Euros in Dengue Vaccine Manufacturing Plant in Germany
KONSTANZ, Germany & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO.
NICE backs anastrozole for breast cancer prevention
The National Institute for Health and Care Excellence is now backing the use of three medicines to prevent breast cancer in women with a family history of the disease, adding anastrozole to the mix fo...
US speedy review for Merck, Pfizer’s avelumab
US regulators have agreed to undertake a priority review EMD Serono's avelumab as a potential treatment for metastatic Merkel cell carcinoma (MCC), a rare and aggressive disease in which c...
Among antidementia drugs, memantine is associated with the highest risk of pneumonia
A recent study from the University of Eastern Finland shows that among users of antidementia drugs, persons using memantine have the highest risk of pneumonia.
Abe orders review of drug pricing system by year-end
TOKYO — Prime Minister Shinzo Abe has instructed his cabinet ministers to review the pricing system for drugs and draw up a basic policy by the end of the year in a bid to curb ballooning medical co...
Australia gets first institute for biofabrication of human bones and tissue
The Herston Health Precinct in Brisbane, Queensland, is in the center of seven of the city’s medical institutes, including the Royal Brisbane and Women’s Hospital (RBWH) that already imple...
Janssen brings psoriasis therapy guselkumab to the EMA
Janssen has filed its potential new psoriasis therapy guselkumab with the European Medicines Agency, hot on the heels of the drug's submission in the US.
World War One antiseptic may become 21st century saviour
A World War One antiseptic could step in both as a frontline anti-viral treatment and a key to the fight against antibiotic resistance.
Neurotrope Completes Enrollment in its Randomized, Double-Blinded, Placebo-Controlled Phase 2 Clinical Trial of Bryostatin in Patients With Moderate to Severe Alzheimer's Disease
NEW YORK, NY, USA I November 22, 2016 I Neurotrope, Inc.
580
581
582
583
584
585
586
587
588
